Tietze’s Syndrome Post-COVID-19 Infection in an Adult Patient

Tan, Charlene; Lim, Rachel; Yeow, Marcus; Fong, Jeffrey T.; Balakrishnan, T. R.

doi:10.7759/cureus.27499

Cited by 4 publications

(4 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other persistent COVID-19 symptoms reported in these patients were shortness of breath (25.3%), hair loss/alopecia (20%) and diaphoresis (17%) ( 154 ). Patients with LC may also present with costochondritis, a benign form of chest wall pain caused by costal cartilage inflammation, often accompanied by severe and difficult-to-treat coughing ( 155 , 156 ). Arthralgia has been extensively described as a common symptom of LC, estimated to occur in at least 1 in 5 patients ( 157 ).…”

Section: Clinical Characterization Of Lcmentioning

confidence: 99%

Long COVID: a review and proposed visualization of the complexity of long COVID

et al. 2023

View full text Add to dashboard Cite

Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus – 2 (SARS-CoV-2) infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected individuals globally and counting. We propose a visual description of the complexity of Long COVID and its pathogenesis that can be used by researchers, clinicians, and public health officials to guide the global effort toward an improved understanding of Long COVID and the eventual mechanism-based provision of care to afflicted patients. The proposed visualization or framework for Long COVID should be an evidence-based, dynamic, modular, and systems-level approach to the condition. Furthermore, with further research such a framework could establish the strength of the relationships between pre-existing conditions (or risk factors), biological mechanisms, and resulting clinical phenotypes and outcomes of Long COVID. Notwithstanding the significant contribution that disparities in access to care and social determinants of health have on outcomes and disease course of long COVID, our model focuses primarily on biological mechanisms. Accordingly, the proposed visualization sets out to guide scientific, clinical, and public health efforts to better understand and abrogate the health burden imposed by long COVID.

show abstract

Section: Clinical Characterization Of Lcmentioning

confidence: 99%

Long COVID: a review and proposed visualization of the complexity of long COVID

et al. 2023

View full text Add to dashboard Cite

show abstract

“…In the current general clinical practice, other causes of chest pain may generally include but are not limited to cardiac, pulmonary, and gastrointestinal causes (eg, gastroesophageal reflux, esophageal spasms etc.) or cancer as well as chest wall pain, which may include muscle pain, rib or vertebral fractures, costochondritis, slipping rib syndrome, painful xiphoid syndrome, fibromyalgia, Tietze's syndrome, herpes zoster, thoracic radiculopathy, intercostal muscle pain or neuralgia, postsurgical pain, radiation etc 21–24 . However, in a subset of patients, persistent chest pain is not explained by any objective findings and is categorized as nonspecific chest pain.…”

Section: Introductionmentioning

confidence: 99%

“…or cancer as well as chest wall pain, which may include muscle pain, rib or vertebral fractures, costochondritis, slipping rib syndrome, painful xiphoid syndrome, fibromyalgia, Tietze's syndrome, herpes zoster, thoracic radiculopathy, intercostal muscle pain or neuralgia, postsurgical pain, radiation etc. [21][22][23][24] However, in a subset of patients, persistent chest pain is not explained by any objective findings and is categorized as nonspecific chest pain. As in other chronic pain cases, these symptoms may be debilitating and without effective treatment or symptom management strategy.…”

Section: Introductionmentioning

confidence: 99%

Persistent chest pain following COVID‐19 infection – A scoping review

Kubrova,

Hallo‐Carrasco,

Klasova

et al. 2024

PM&R

View full text Add to dashboard Cite

IntroductionPersistent chest pain (PCP) following acute COVID‐19 infection is a commonly reported symptom with an unclear etiology, making its management challenging. This scoping review aims to address the knowledge gap surrounding the characteristics of PCP following COVID‐19, its causes, and potential treatments.ObjectiveTo assess the prevalence, causes, and potential treatments of PCP following COVID‐19 infection.DesignA scoping review of 64 studies, including observational (prospective, retrospective, cross‐sectional, case series, and case‐control) and one quasi‐experimental study, from databases including Embase, PubMed/MEDLINE, Cochrane CENTRAL, Google Scholar, Cochrane Database of Systematic Reviews, and Scopus.SettingStudies on patients with PCP following mild, moderate, and severe COVID‐19 infection.PatientsStudies that included patients of any age, with chest pain that persisted following acute COVID‐19 disease, irrespective of etiology or duration.InterventionsNot applicable.Main Outcome Measure(s)Prevalence, causes, and potential treatments of PCP following COVID‐19 infection.ResultsA total of 35 studies reported PCP symptoms following COVID‐19 (0.24‐76.6%) at an average follow‐up of three months or longer, 12 studies at 1‐3 months and 17 studies at less than one month follow‐up or not specified. PCP was common following mild ‐ severe COVID‐19 infection, and etiology was mostly not reported. Fourteen studies proposed potential etiologies including endothelial dysfunction, cardiac ischemia, vasospasm, myocarditis, cardiac arrhythmia, pneumonia, pulmonary embolism, postural tachycardia syndrome (POTS), or noted cardiac MRI (cMRI) changes. Evaluation methods included common cardiopulmonary tests, as well as less common tests such as flow‐mediated dilatation (FMD), cMRI, single‐photon emission computed tomography myocardial perfusion imaging (SPECT‐MPI), and cardiopulmonary exercise testing (CPET). Only one study reported a specific treatment (sulodexide).ConclusionsPCP is a prevalent symptom following COVID‐19 infection, with various proposed etiologies. Further research is needed to establish a better understanding of the causes and to develop targeted treatments for PCP following COVID‐19.This article is protected by copyright. All rights reserved.

show abstract

“…In some cases, pain may cover not only the chest region but the arm and shoulder as well. Tietze syndrome has been associated with viral or bacterial infections, albeit some post-coronavirus disease 2019 (COVID-19) cases have been reported [ 2 ].…”

Section: Introductionmentioning

confidence: 99%

Tietze Syndrome as a Cause of Chest Pain in the Post-COVID-19 Period

Kuridze¹,

Okuashvili²,

Tsverava³

et al. 2023

Cureus

View full text Add to dashboard Cite

Tietze syndrome is a rare disease. It is mainly characterized by chest pain caused by a unilateral and monoarticular lesion of the second-fifth costal joints. Tietze syndrome is one of the potential complications in the post-COVID-19 period. It is one of the differential diagnoses for non-ischemic chest pain. With early diagnosis and appropriate treatment, this syndrome is easily manageable. The authors present a case of a 38-year-old male who had been diagnosed with Tietze syndrome in the post-coronavirus disease 2019 (COVID-19) period.

show abstract

Tietze’s Syndrome Post-COVID-19 Infection in an Adult Patient

Cited by 4 publications

References 7 publications

Long COVID: a review and proposed visualization of the complexity of long COVID

Long COVID: a review and proposed visualization of the complexity of long COVID

Persistent chest pain following COVID‐19 infection – A scoping review

Tietze Syndrome as a Cause of Chest Pain in the Post-COVID-19 Period

Contact Info

Product

Resources

About